Summit X, LLC Sana Biotechnology, Inc. Transaction History
Summit X, LLC
- $460 Million
- Q1 2025
A detailed history of Summit X, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Summit X, LLC holds 36,000 shares of SANA stock, worth $67,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,000Holding current value
$67,320% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding SANA
# of Institutions
180Shares Held
119MCall Options Held
1.77MPut Options Held
901K-
Flagship Pioneering Inc. Cambridge, MA25MShares$46.8 Million12.19% of portfolio
-
Black Rock Inc. New York, NY11MShares$20.7 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$19.1 Million0.02% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$19 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.87MShares$14.7 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $356M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...